Status:

RECRUITING

Deconstructing Voice Therapy: Towards Enhanced Communication Outcomes

Lead Sponsor:

Emory University

Collaborating Sponsors:

National Institute on Deafness and Other Communication Disorders (NIDCD)

Conditions:

Dysphonia

Primary Muscle Tension Dysphonia (MTD)

Eligibility:

All Genders

16-65 years

Phase:

NA

Brief Summary

This research study aims to evaluate the effect of treatment delivery method on voice outcomes over 12 months in people with a primary complaint of a voice problem, diagnosed with either non-phonotrau...

Detailed Description

About 23 million Americans-roughly 1 in 13 people-suffer from voice problems at any given time. These issues can make it hard to speak clearly, lead to throat pain or fatigue, and affect daily life, w...

Eligibility Criteria

Inclusion

  • Non-smoking
  • Diagnosis of either primary muscle tension dysphonia of the hyperadducted type or benign vocal fold lesions.
  • No neuro-laryngologic or age-related vocal fold changes (e.g., atrophy)
  • No history of voice therapy or voice surgery in the last year
  • No history of other serious chronic medical conditions that may affect voice (per patient report), Normal hearing (determined by pure tone audiometry), stimulable and appropriate for behavioral voice intervention as determined by a voice-specialized speech-language pathologist and laryngologist,
  • Willingness to attend all therapeutic interventions and follow-up sessions
  • Willingness to use a smartphone to record practice

Exclusion

  • History of voice therapy or voice surgery in the last year
  • Serious chronic medical condition that may affect voice (per patient report)
  • Abnormal hearing ability (despite appropriate amplification)
  • Other laryngeal disorders not attributed to primary MTD and benign vocal fold lesions,
  • Not stimulable or inappropriate for behavioral voice intervention as determined by a voice-specialized speech-language pathologist and laryngologist
  • Unwillingness to attend therapeutic intervention and follow-up sessions
  • Unwillingness to use a smartphone to record practice
  • Pregnant women
  • Prisoners
  • Cognitive impairment or impaired decision-making capacity

Key Trial Info

Start Date :

September 3 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

April 1 2029

Estimated Enrollment :

120 Patients enrolled

Trial Details

Trial ID

NCT07176988

Start Date

September 3 2025

End Date

April 1 2029

Last Update

October 17 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Emory Voice Center at Emory University Hospital Midtown

Atlanta, Georgia, United States, 30308